Covestor
ANVS icon

Covestor’s Annovis Bio ANVS Stock Holding History

Covestor’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6K Buy
4,863
+229
+5% +$373 ﹤0.01% 1770
2026
Q2 		$9K Buy
4,634
+2,289
+98% +$4.45K 0.01% 1639
2026
Q1 		$5K Buy
2,345
+6
+0.3% +$16 ﹤0.01% 1772
2025
Q4 		$8K Hold
2,339
– – ﹤0.01% 1672
2025
Q3 		$5K Hold
2,339
– – ﹤0.01% 1843
2025
Q2 		$5K Buy
2,339
+463
+25% +$914 ﹤0.01% 1742
2025
Q1 		$3K Buy
+1,876
New +$5.74K ﹤0.01% 1767

Other funds holding ANVS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
SG
Sherry Group Mountain Home, Arkansas $107M AUM 11.17% 1-Year Est. Return
Wescott Financial Advisory Group
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.36B AUM 14.05% 1-Year Est. Return
CWA Asset Management Group
CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Sterling Investment Advisors (Pennsylvania)
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $606M AUM 21.78% 1-Year Est. Return
Nicholson Wealth Management Group
Nicholson Wealth Management Group Charlestown, South Carolina $168M AUM 6.36% 1-Year Est. Return
Gill Capital Partners
Gill Capital Partners Denver, Colorado $366M AUM 12.21% 1-Year Est. Return
Robertson Stephens Wealth Management
Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Covestor's ANVS Position: Q3 2026 in Review

Covestor increased its Annovis Bio (ANVS) stake by 4.9% in Q3 2026, buying an estimated $373 and bringing the position to 4,863 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #1770.

Covestor first reported a position in ANVS in Q1 2025 and has held it in 7 quarters since. The position peaked at $9K in Q2 2026. 30 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.

  • Covestor held 4,863 shares of Annovis Bio worth $6K as of Q3 2026.
  • Covestor bought 229 Annovis Bio shares in Q3 2026, an estimated $373.
  • Annovis Bio made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #1770 holding.
  • Covestor first reported a position in Annovis Bio in Q1 2025 and has held it in 7 quarters since.
  • Covestor's Annovis Bio position peaked at $9K in Q2 2026.
  • 30 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.